CELC vs VCYT: stock comparison and AI forecast
Celcuity Inc. (CELC) and Veracyte, Inc. (VCYT) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CELC Celcuity Inc.
- Price
- $69.13 -43.0% · 6M
- Market Cap
- $3.38B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
- NO CURRENT FORECAST
VCYT Veracyte, Inc.
- Price
- $50.29 +52.5% · 6M
- Market Cap
- $4.22B
- P/E Ratio
- 46.1x
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- VCYT is 1.2 times larger than CELC by market capitalization ($4.22B against $3.38B).
- Over the last six months VCYT returned +52.5% and CELC -43.0%.
- Both companies share the SEC industry classification Services-Medical Laboratories.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CELC | VCYT |
|---|---|---|
| Market Cap | $3.38B | $4.22B |
| P/E Ratio | – | 46.07x |
| P/B Ratio | – | 3.04x |
| EPS | $-4.19 | $1.14 |
| Book Value/Share | – | $17.27 |
| Revenue/Share | – | $6.99 |
| FCF/Share | $-3.93 | $2.06 |
Profitability & Margins
| Metric | CELC | VCYT |
|---|---|---|
| ROE | – | 8.2% |
| ROA | -27.4% | 7.7% |
| ROIC | -28.1% | 7.4% |
| Gross Margin | – | 71.7% |
| Operating Margin | – | 18.8% |
| Net Margin | – | 20.4% |
| EBT Margin | – | 20.6% |
| Tax Rate | – | 1.3% |
Financial Health
| Metric | CELC | VCYT |
|---|---|---|
| Current Ratio | 8.93x | 9.16x |
| Quick Ratio | – | 8.80x |
| D/E Ratio | – | 0.07x |
| Financial Leverage | – | 1.07x |
| Interest Coverage | -18.9x | – |
| Working Capital | $689M | $512M |
Cash Flow
| Metric | CELC | VCYT |
|---|---|---|
| Operating Cash Flow | -$192M | $178M |
| Free Cash Flow | -$192M | $166M |
| Capital Spending | -$450K | -$12M |
| OCF Growth YoY | – | 90.9% |
| FCF Growth YoY | – | 97.7% |
| FCF/Sales | – | 29.5% |
| CapEx/Sales | – | 2.2% |
Operational Efficiency
| Metric | CELC | VCYT |
|---|---|---|
| Asset Turnover | – | 0.38x |
| Receivables Turnover | – | 10.4x |
| Fixed Assets Turnover | – | 25.6x |
| Days Sales Outstanding | – | 35 days |
Income Statement
| Metric | CELC | VCYT |
|---|---|---|
| Total Revenue | – | $562M |
| Operating Income | -$209M | $106M |
| Net Income | -$226M | $114M |
| R&D Expense | $137M | $93M |
| SG&A Expense | – | $302M |
Dividend & Shareholder Information
| Metric | CELC | VCYT |
|---|---|---|
| Shares Outstanding | 49M | 80M |
| Net Income Growth | – | 334.7% |
| EPS Growth | – | 395.6% |
CELC vs VCYT: stock comparison and AI forecast
Which is bigger, CELC or VCYT?
VCYT is 1.2 times larger than CELC by market capitalization ($4.22B against $3.38B).
Which stock performed better over the last six months, CELC or VCYT?
Over the last six months VCYT returned +52.5% and CELC -43.0%.
Which one does Intratio's AI model rank higher, CELC or VCYT?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.